Culley Brian M — SEC insider filings

SEC reporting owner CIK 1310683. 25 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2020-09-30 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lineage Cell Therapeutics, Inc. (LCTX)President and CEO, Director256 legs · 117,150 sh · $113,0101 leg · 450,000 sh · $1,291,50048

Insider filings — Culley Brian M

FiledFormIssuerReported transactionsSource
2026-11-174Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 40,500 @ $0.92EDGAR
2026-03-124Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 15,000 @ $1.62EDGAR
2026-03-064Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 3,250,000 (derivative) @ $0EDGAR
2026-02-134Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 31,250 · Tax withholding (F): 12,869 @ $1.80 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2025-12-194Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 8,925 · Tax withholding (F): 334 @ $1.68EDGAR
2025-03-124Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 2,300,000 (derivative) @ $0EDGAR
2025-02-124Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 31,249 · Tax withholding (F): 12,547 @ $0.65 · Option exercise (M): 31,249 (derivative) @ $0EDGAR
2024-11-224Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 40,000 @ $0.60EDGAR
2024-05-284Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 10,000 @ $1.05EDGAR
2024-03-084Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 1,900,000 (derivative) @ $0EDGAR
2024-02-124Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 31,249 · Tax withholding (F): 12,806 @ $1.08 · Option exercise (M): 31,249 (derivative) @ $0EDGAR
2023-03-104Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 1,900,000 (derivative) @ $0EDGAR
2023-02-144Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 31,249 · Tax withholding (F): 12,744 @ $1.35 · Option exercise (M): 31,249 (derivative) @ $0EDGAR
2022-06-304Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 15,450 · Tax withholding (F): 5,343 @ $1.58 · Option exercise (M): 15,450 (derivative) @ $0EDGAR
2022-04-044Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 15,450 · Tax withholding (F): 5,343 @ $1.54 · Purchase (P): 6,400 @ $1.53 · Option exercise (M): 15,450 (derivative) @ $0EDGAR
2022-03-284Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 5,250 @ $1.38EDGAR
2022-03-114Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 1,250,000 (derivative) @ $0 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2022-02-154Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 124,997 (derivative) @ $0EDGAR
2022-01-034Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 15,450 · Tax withholding (F): 5,343 @ $2.45 · Option exercise (M): 15,450 (derivative) @ $0EDGAR
2021-10-124Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 15,450 · Tax withholding (F): 5,343 @ $2.52 · Option exercise (M): 15,450 (derivative) @ $0EDGAR
2021-06-304Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 300,000 @ $0.69 · Sale (S): 450,000 @ $2.87 · Option exercise (M): 15,450 @ $2.85 · Tax withholding (F): 5,343 @ $2.85 · Option exercise (M): 300,000 (derivative) @ $0 · Option exercise (M): 15,450 (derivative) @ $0EDGAR
2021-04-014Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 15,450 @ $2.35 · Tax withholding (F): 5,343 @ $2.35 · Option exercise (M): 15,450 (derivative) @ $0EDGAR
2021-03-174Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 1,165,100 (derivative) @ $0EDGAR
2020-12-314Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 15,450 @ $1.76 · Tax withholding (F): 5,343 @ $1.76 · Option exercise (M): 15,450 (derivative) @ $0EDGAR
2020-09-304Lineage Cell Therapeutics, Inc. (LCTX)Option exercise (M): 15,450 @ $0.94 · Tax withholding (F): 5,343 @ $0.94 · Option exercise (M): 15,450 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1310683 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs